PRINCETON, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Covance Inc. today announced that it will present at the UBS Global Life Sciences Conference on September 24 at 3:30 pm ET. Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.
Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,400 employees worldwide. Information on Covance’s products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.
Covance Inc.
CONTACT: Investor Relations, +1-609-452-4807
Web site: http://www.covance.com/
